Schedule 13D ownership disclosure

Supernus Pharmaceuticals Inc

Security class unavailable · CUSIP: 868459108

Event date: 2015-11-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001072613-15-000474
Form type
SC 13D/A
Filer
NEW ENTERPRISE ASSOCIATES 11 LP
CIK
CIK 1243094
Filed
Nov 24, 2015
Reporting period
Nov 11, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub